Search results
Kite and Arcellx Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
Morningstar· 7 days agoKite, a Gilead Company (NASDAQ: GILD), and Arcellx, Inc. (NASDAQ: ACLX) today announced several key operational updates on their partnered anitocabtagene autoleucel (anito-cel) multiple ...
General Hospital Comings And Goings: John J. York Returns – Will Mac Learn Cody’s His Son?
SOAPHUB via Yahoo News· 6 days agoA fan favorite has returned to GH much to the delight of his many supporters. The post General...
These 2 No-Brainer Growth Stocks Are Breaking New Ground
Motley Fool via Yahoo Finance· 5 hours agoRegeneron's pipeline is also bright. The company is looking to ramp up its oncology unit and is...
Poseida Therapeutics Provides Updates and Financial Results for the First Quarter of 2024
Yucaipa News Mirror· 2 days agoExpanded strategic relationship with Astellas with new research collaboration leveraging Poseida's proprietary allogeneic CAR-T platform to develop cell therapies targeting solid tumors
7 cancer disparities to watch for in 2024
Becker’s Hospital Review· 9 hours agoIn 2024, more than 2 million new cancer cases are projected to be diagnosed, and more than 611,700 deaths from cancer are expected, a May American Association of Cancer Research report found ...
Report shows disparities in cancer outcomes based on race, location, sexuality
United Press International via Yahoo News· 1 day agoRace, location and sexuality all play a role in cancer disparities across the United States,...
Immix Biopharma Inc (IMMX) Stock Sees a-7.34 Decrease – News Heater
NewsHeater· 6 days agoIn the past week, IMMX stock has gone down by -14.04%, with a monthly decline of -30.10% and a quarterly plunge of -37.65%. The volatility ratio for the week is 8.63%, and the volatility levels ...
Syndax Pharmaceuticals Appoints Aleksandra Rizo, M.D., Ph.D. to the Board of Directors
The Woonsocket Call· 20 hours agoSyndax Pharmaceuticals (Nasdaq: SNDX), a clinical-stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today announced the appointment of ...
Big Pharma layoffs continue, as Bristol-Myers Squibb cuts 2,200 jobs, $1.5B in costs
BenefitsPRO· 6 days agoAt a time when drugmakers Eli Lilly & Co. and Novo Nordisk are scrambling to meet demand for their...
Earnings call: AbbVie projects robust growth and diversified pipeline
Investing.com· 1 day agoWith a growth platform that accounts for 80% of AbbVie's business, the company saw mid-teens growth...
